img

Global Codeine Narcotic Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Codeine Narcotic Market Insights, Forecast to 2034

Codeine is an opiate used to treat pain, coughing, and diarrhea. It is typically used to treat mild to moderate degrees of pain.
Global Codeine Narcotic market is expected to reach to US$ 716 million in 2024, with a positive growth of %, compared with US$ 681.5 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Codeine Narcotic industry is evaluated to reach US$ 965 million in 2029. The CAGR will be 5.1% during 2024 to 2029.
The Codeine Narcotic market is driven by the demand for effective pain management and the widespread use of codeine as an analgesic and antitussive medication. Codeine, a narcotic drug derived from opium, is prescribed to alleviate moderate to severe pain and suppress coughing. The prevalence of conditions causing pain, such as post-surgery recovery and chronic illnesses, contributes to market growth as healthcare professionals seek safe and accessible pain relief options. Moreover, codeine's relatively lower potential for abuse compared to other narcotics aligns with its continued medical use. However, the market also faces challenges, including the potential for misuse and addiction due to codeine's opioid properties, leading to regulatory controls and prescription limitations in various regions. Additionally, addressing patient education about codeine's potential risks and benefits, and ensuring proper dosing and monitoring can pose obstacles for healthcare providers. To succeed, pharmaceutical companies must focus on responsible prescribing practices, patient education, and addressing the challenges to ensure the appropriate use of codeine while providing effective pain management solutions that prioritize patient safety.
Report Covers
This report presents an overview of global Codeine Narcotic market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Codeine Narcotic market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Taiji
Mallinckrodt
TEVA
Johnson & Johnson
Medreich
Sanofi Aventis
Cipla
Hikma
Pharmaceutical Associates
Novartis
Apotex
Mylan
Aristo Pharma GmbH
Lannett Company
Laboratoire Riva
Segment by Type
Single-ingredient Codeine
Multi-ingredient Medications

Segment by Application


Narcotic Analgesic
Antitussive
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Codeine Narcotic plant distribution, commercial date of Codeine Narcotic, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Codeine Narcotic introduction, etc. Codeine Narcotic Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Codeine Narcotic
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Codeine Narcotic Product Introduction
1.2 Market by Type
1.2.1 Global Codeine Narcotic Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Single-ingredient Codeine
1.2.3 Multi-ingredient Medications
1.3 Market by Application
1.3.1 Global Codeine Narcotic Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Narcotic Analgesic
1.3.3 Antitussive
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Codeine Narcotic Sales Estimates and Forecasts 2018-2029
2.2 Global Codeine Narcotic Revenue by Region
2.2.1 Global Codeine Narcotic Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Codeine Narcotic Revenue by Region (2018-2024)
2.2.3 Global Codeine Narcotic Revenue by Region (2024-2029)
2.2.4 Global Codeine Narcotic Revenue Market Share by Region (2018-2029)
2.3 Global Codeine Narcotic Sales Estimates and Forecasts 2018-2029
2.4 Global Codeine Narcotic Sales by Region
2.4.1 Global Codeine Narcotic Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Codeine Narcotic Sales by Region (2018-2024)
2.4.3 Global Codeine Narcotic Sales by Region (2024-2029)
2.4.4 Global Codeine Narcotic Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Codeine Narcotic Sales by Manufacturers
3.1.1 Global Codeine Narcotic Sales by Manufacturers (2018-2024)
3.1.2 Global Codeine Narcotic Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Codeine Narcotic in 2022
3.2 Global Codeine Narcotic Revenue by Manufacturers
3.2.1 Global Codeine Narcotic Revenue by Manufacturers (2018-2024)
3.2.2 Global Codeine Narcotic Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Codeine Narcotic Revenue in 2022
3.3 Global Key Players of Codeine Narcotic, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Codeine Narcotic Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Codeine Narcotic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Codeine Narcotic, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Codeine Narcotic, Product Offered and Application
3.8 Global Key Manufacturers of Codeine Narcotic, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Codeine Narcotic Sales by Type
4.1.1 Global Codeine Narcotic Historical Sales by Type (2018-2024)
4.1.2 Global Codeine Narcotic Forecasted Sales by Type (2024-2029)
4.1.3 Global Codeine Narcotic Sales Market Share by Type (2018-2029)
4.2 Global Codeine Narcotic Revenue by Type
4.2.1 Global Codeine Narcotic Historical Revenue by Type (2018-2024)
4.2.2 Global Codeine Narcotic Forecasted Revenue by Type (2024-2029)
4.2.3 Global Codeine Narcotic Revenue Market Share by Type (2018-2029)
4.3 Global Codeine Narcotic Price by Type
4.3.1 Global Codeine Narcotic Price by Type (2018-2024)
4.3.2 Global Codeine Narcotic Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Codeine Narcotic Sales by Application
5.1.1 Global Codeine Narcotic Historical Sales by Application (2018-2024)
5.1.2 Global Codeine Narcotic Forecasted Sales by Application (2024-2029)
5.1.3 Global Codeine Narcotic Sales Market Share by Application (2018-2029)
5.2 Global Codeine Narcotic Revenue by Application
5.2.1 Global Codeine Narcotic Historical Revenue by Application (2018-2024)
5.2.2 Global Codeine Narcotic Forecasted Revenue by Application (2024-2029)
5.2.3 Global Codeine Narcotic Revenue Market Share by Application (2018-2029)
5.3 Global Codeine Narcotic Price by Application
5.3.1 Global Codeine Narcotic Price by Application (2018-2024)
5.3.2 Global Codeine Narcotic Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Codeine Narcotic Market Size by Type
6.1.1 US & Canada Codeine Narcotic Sales by Type (2018-2029)
6.1.2 US & Canada Codeine Narcotic Revenue by Type (2018-2029)
6.2 US & Canada Codeine Narcotic Market Size by Application
6.2.1 US & Canada Codeine Narcotic Sales by Application (2018-2029)
6.2.2 US & Canada Codeine Narcotic Revenue by Application (2018-2029)
6.3 US & Canada Codeine Narcotic Market Size by Country
6.3.1 US & Canada Codeine Narcotic Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Codeine Narcotic Sales by Country (2018-2029)
6.3.3 US & Canada Codeine Narcotic Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Codeine Narcotic Market Size by Type
7.1.1 Europe Codeine Narcotic Sales by Type (2018-2029)
7.1.2 Europe Codeine Narcotic Revenue by Type (2018-2029)
7.2 Europe Codeine Narcotic Market Size by Application
7.2.1 Europe Codeine Narcotic Sales by Application (2018-2029)
7.2.2 Europe Codeine Narcotic Revenue by Application (2018-2029)
7.3 Europe Codeine Narcotic Market Size by Country
7.3.1 Europe Codeine Narcotic Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Codeine Narcotic Sales by Country (2018-2029)
7.3.3 Europe Codeine Narcotic Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Codeine Narcotic Market Size
8.1.1 China Codeine Narcotic Sales (2018-2029)
8.1.2 China Codeine Narcotic Revenue (2018-2029)
8.2 China Codeine Narcotic Market Size by Application
8.2.1 China Codeine Narcotic Sales by Application (2018-2029)
8.2.2 China Codeine Narcotic Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Codeine Narcotic Market Size by Type
9.1.1 Asia Codeine Narcotic Sales by Type (2018-2029)
9.1.2 Asia Codeine Narcotic Revenue by Type (2018-2029)
9.2 Asia Codeine Narcotic Market Size by Application
9.2.1 Asia Codeine Narcotic Sales by Application (2018-2029)
9.2.2 Asia Codeine Narcotic Revenue by Application (2018-2029)
9.3 Asia Codeine Narcotic Sales by Region
9.3.1 Asia Codeine Narcotic Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Codeine Narcotic Revenue by Region (2018-2029)
9.3.3 Asia Codeine Narcotic Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Codeine Narcotic Market Size by Type
10.1.1 Middle East, Africa and Latin America Codeine Narcotic Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Codeine Narcotic Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Codeine Narcotic Market Size by Application
10.2.1 Middle East, Africa and Latin America Codeine Narcotic Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Codeine Narcotic Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Codeine Narcotic Sales by Country
10.3.1 Middle East, Africa and Latin America Codeine Narcotic Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Codeine Narcotic Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Codeine Narcotic Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Taiji
11.1.1 Taiji Company Information
11.1.2 Taiji Overview
11.1.3 Taiji Codeine Narcotic Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Taiji Codeine Narcotic Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Taiji Recent Developments
11.2 Mallinckrodt
11.2.1 Mallinckrodt Company Information
11.2.2 Mallinckrodt Overview
11.2.3 Mallinckrodt Codeine Narcotic Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Mallinckrodt Codeine Narcotic Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Mallinckrodt Recent Developments
11.3 TEVA
11.3.1 TEVA Company Information
11.3.2 TEVA Overview
11.3.3 TEVA Codeine Narcotic Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 TEVA Codeine Narcotic Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 TEVA Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Information
11.4.2 Johnson & Johnson Overview
11.4.3 Johnson & Johnson Codeine Narcotic Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Johnson & Johnson Codeine Narcotic Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Johnson & Johnson Recent Developments
11.5 Medreich
11.5.1 Medreich Company Information
11.5.2 Medreich Overview
11.5.3 Medreich Codeine Narcotic Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Medreich Codeine Narcotic Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Medreich Recent Developments
11.6 Sanofi Aventis
11.6.1 Sanofi Aventis Company Information
11.6.2 Sanofi Aventis Overview
11.6.3 Sanofi Aventis Codeine Narcotic Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Sanofi Aventis Codeine Narcotic Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Sanofi Aventis Recent Developments
11.7 Cipla
11.7.1 Cipla Company Information
11.7.2 Cipla Overview
11.7.3 Cipla Codeine Narcotic Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Cipla Codeine Narcotic Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Cipla Recent Developments
11.8 Hikma
11.8.1 Hikma Company Information
11.8.2 Hikma Overview
11.8.3 Hikma Codeine Narcotic Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Hikma Codeine Narcotic Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Hikma Recent Developments
11.9 Pharmaceutical Associates
11.9.1 Pharmaceutical Associates Company Information
11.9.2 Pharmaceutical Associates Overview
11.9.3 Pharmaceutical Associates Codeine Narcotic Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Pharmaceutical Associates Codeine Narcotic Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Pharmaceutical Associates Recent Developments
11.10 Novartis
11.10.1 Novartis Company Information
11.10.2 Novartis Overview
11.10.3 Novartis Codeine Narcotic Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Novartis Codeine Narcotic Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Novartis Recent Developments
11.11 Apotex
11.11.1 Apotex Company Information
11.11.2 Apotex Overview
11.11.3 Apotex Codeine Narcotic Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Apotex Codeine Narcotic Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Apotex Recent Developments
11.12 Mylan
11.12.1 Mylan Company Information
11.12.2 Mylan Overview
11.12.3 Mylan Codeine Narcotic Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Mylan Codeine Narcotic Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Mylan Recent Developments
11.13 Aristo Pharma GmbH
11.13.1 Aristo Pharma GmbH Company Information
11.13.2 Aristo Pharma GmbH Overview
11.13.3 Aristo Pharma GmbH Codeine Narcotic Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Aristo Pharma GmbH Codeine Narcotic Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Aristo Pharma GmbH Recent Developments
11.14 Lannett Company
11.14.1 Lannett Company Company Information
11.14.2 Lannett Company Overview
11.14.3 Lannett Company Codeine Narcotic Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Lannett Company Codeine Narcotic Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Lannett Company Recent Developments
11.15 Laboratoire Riva
11.15.1 Laboratoire Riva Company Information
11.15.2 Laboratoire Riva Overview
11.15.3 Laboratoire Riva Codeine Narcotic Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Laboratoire Riva Codeine Narcotic Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Laboratoire Riva Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Codeine Narcotic Industry Chain Analysis
12.2 Codeine Narcotic Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Codeine Narcotic Production Mode & Process
12.4 Codeine Narcotic Sales and Marketing
12.4.1 Codeine Narcotic Sales Channels
12.4.2 Codeine Narcotic Distributors
12.5 Codeine Narcotic Customers
13 Market Dynamics
13.1 Codeine Narcotic Industry Trends
13.2 Codeine Narcotic Market Drivers
13.3 Codeine Narcotic Market Challenges
13.4 Codeine Narcotic Market Restraints
14 Key Findings in The Global Codeine Narcotic Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Codeine Narcotic Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Single-ingredient Codeine
Table 3. Major Manufacturers of Multi-ingredient Medications
Table 4. Global Codeine Narcotic Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Codeine Narcotic Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Codeine Narcotic Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Codeine Narcotic Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Codeine Narcotic Revenue Market Share by Region (2018-2024)
Table 9. Global Codeine Narcotic Revenue Market Share by Region (2024-2029)
Table 10. Global Codeine Narcotic Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Codeine Narcotic Sales by Region (2018-2024) & (K Units)
Table 12. Global Codeine Narcotic Sales by Region (2024-2029) & (K Units)
Table 13. Global Codeine Narcotic Sales Market Share by Region (2018-2024)
Table 14. Global Codeine Narcotic Sales Market Share by Region (2024-2029)
Table 15. Global Codeine Narcotic Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Codeine Narcotic Sales Share by Manufacturers (2018-2024)
Table 17. Global Codeine Narcotic Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Codeine Narcotic Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Codeine Narcotic, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Codeine Narcotic Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global Codeine Narcotic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Codeine Narcotic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Codeine Narcotic as of 2022)
Table 23. Global Key Manufacturers of Codeine Narcotic, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Codeine Narcotic, Product Offered and Application
Table 25. Global Key Manufacturers of Codeine Narcotic, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Codeine Narcotic Sales by Type (2018-2024) & (K Units)
Table 28. Global Codeine Narcotic Sales by Type (2024-2029) & (K Units)
Table 29. Global Codeine Narcotic Sales Share by Type (2018-2024)
Table 30. Global Codeine Narcotic Sales Share by Type (2024-2029)
Table 31. Global Codeine Narcotic Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Codeine Narcotic Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Codeine Narcotic Revenue Share by Type (2018-2024)
Table 34. Global Codeine Narcotic Revenue Share by Type (2024-2029)
Table 35. Codeine Narcotic Price by Type (2018-2024) & (US$/Unit)
Table 36. Global Codeine Narcotic Price Forecast by Type (2024-2029) & (US$/Unit)
Table 37. Global Codeine Narcotic Sales by Application (2018-2024) & (K Units)
Table 38. Global Codeine Narcotic Sales by Application (2024-2029) & (K Units)
Table 39. Global Codeine Narcotic Sales Share by Application (2018-2024)
Table 40. Global Codeine Narcotic Sales Share by Application (2024-2029)
Table 41. Global Codeine Narcotic Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Codeine Narcotic Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Codeine Narcotic Revenue Share by Application (2018-2024)
Table 44. Global Codeine Narcotic Revenue Share by Application (2024-2029)
Table 45. Codeine Narcotic Price by Application (2018-2024) & (US$/Unit)
Table 46. Global Codeine Narcotic Price Forecast by Application (2024-2029) & (US$/Unit)
Table 47. US & Canada Codeine Narcotic Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Codeine Narcotic Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Codeine Narcotic Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Codeine Narcotic Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Codeine Narcotic Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Codeine Narcotic Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Codeine Narcotic Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Codeine Narcotic Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Codeine Narcotic Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Codeine Narcotic Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Codeine Narcotic Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Codeine Narcotic Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Codeine Narcotic Sales by Country (2024-2029) & (K Units)
Table 60. Europe Codeine Narcotic Sales by Type (2018-2024) & (K Units)
Table 61. Europe Codeine Narcotic Sales by Type (2024-2029) & (K Units)
Table 62. Europe Codeine Narcotic Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Codeine Narcotic Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Codeine Narcotic Sales by Application (2018-2024) & (K Units)
Table 65. Europe Codeine Narcotic Sales by Application (2024-2029) & (K Units)
Table 66. Europe Codeine Narcotic Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Codeine Narcotic Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Codeine Narcotic Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Codeine Narcotic Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Codeine Narcotic Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Codeine Narcotic Sales by Country (2018-2024) & (K Units)
Table 72. Europe Codeine Narcotic Sales by Country (2024-2029) & (K Units)
Table 73. China Codeine Narcotic Sales by Type (2018-2024) & (K Units)
Table 74. China Codeine Narcotic Sales by Type (2024-2029) & (K Units)
Table 75. China Codeine Narcotic Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Codeine Narcotic Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Codeine Narcotic Sales by Application (2018-2024) & (K Units)
Table 78. China Codeine Narcotic Sales by Application (2024-2029) & (K Units)
Table 79. China Codeine Narcotic Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Codeine Narcotic Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Codeine Narcotic Sales by Type (2018-2024) & (K Units)
Table 82. Asia Codeine Narcotic Sales by Type (2024-2029) & (K Units)
Table 83. Asia Codeine Narcotic Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Codeine Narcotic Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Codeine Narcotic Sales by Application (2018-2024) & (K Units)
Table 86. Asia Codeine Narcotic Sales by Application (2024-2029) & (K Units)
Table 87. Asia Codeine Narcotic Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Codeine Narcotic Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Codeine Narcotic Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Codeine Narcotic Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Codeine Narcotic Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Codeine Narcotic Sales by Region (2018-2024) & (K Units)
Table 93. Asia Codeine Narcotic Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Codeine Narcotic Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Codeine Narcotic Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Codeine Narcotic Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Codeine Narcotic Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Codeine Narcotic Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Codeine Narcotic Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Codeine Narcotic Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Codeine Narcotic Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Codeine Narcotic Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Codeine Narcotic Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Codeine Narcotic Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Codeine Narcotic Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Codeine Narcotic Sales by Country (2024-2029) & (K Units)
Table 107. Taiji Company Information
Table 108. Taiji Description and Major Businesses
Table 109. Taiji Codeine Narcotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Taiji Codeine Narcotic Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Taiji Recent Developments
Table 112. Mallinckrodt Company Information
Table 113. Mallinckrodt Description and Major Businesses
Table 114. Mallinckrodt Codeine Narcotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Mallinckrodt Codeine Narcotic Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Mallinckrodt Recent Developments
Table 117. TEVA Company Information
Table 118. TEVA Description and Major Businesses
Table 119. TEVA Codeine Narcotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. TEVA Codeine Narcotic Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. TEVA Recent Developments
Table 122. Johnson & Johnson Company Information
Table 123. Johnson & Johnson Description and Major Businesses
Table 124. Johnson & Johnson Codeine Narcotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Johnson & Johnson Codeine Narcotic Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Johnson & Johnson Recent Developments
Table 127. Medreich Company Information
Table 128. Medreich Description and Major Businesses
Table 129. Medreich Codeine Narcotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Medreich Codeine Narcotic Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Medreich Recent Developments
Table 132. Sanofi Aventis Company Information
Table 133. Sanofi Aventis Description and Major Businesses
Table 134. Sanofi Aventis Codeine Narcotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Sanofi Aventis Codeine Narcotic Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Sanofi Aventis Recent Developments
Table 137. Cipla Company Information
Table 138. Cipla Description and Major Businesses
Table 139. Cipla Codeine Narcotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Cipla Codeine Narcotic Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Cipla Recent Developments
Table 142. Hikma Company Information
Table 143. Hikma Description and Major Businesses
Table 144. Hikma Codeine Narcotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Hikma Codeine Narcotic Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Hikma Recent Developments
Table 147. Pharmaceutical Associates Company Information
Table 148. Pharmaceutical Associates Description and Major Businesses
Table 149. Pharmaceutical Associates Codeine Narcotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. Pharmaceutical Associates Codeine Narcotic Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Pharmaceutical Associates Recent Developments
Table 152. Novartis Company Information
Table 153. Novartis Description and Major Businesses
Table 154. Novartis Codeine Narcotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. Novartis Codeine Narcotic Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Novartis Recent Developments
Table 157. Apotex Company Information
Table 158. Apotex Description and Major Businesses
Table 159. Apotex Codeine Narcotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. Apotex Codeine Narcotic Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Apotex Recent Developments
Table 162. Mylan Company Information
Table 163. Mylan Description and Major Businesses
Table 164. Mylan Codeine Narcotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 165. Mylan Codeine Narcotic Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Mylan Recent Developments
Table 167. Aristo Pharma GmbH Company Information
Table 168. Aristo Pharma GmbH Description and Major Businesses
Table 169. Aristo Pharma GmbH Codeine Narcotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 170. Aristo Pharma GmbH Codeine Narcotic Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Aristo Pharma GmbH Recent Developments
Table 172. Lannett Company Company Information
Table 173. Lannett Company Description and Major Businesses
Table 174. Lannett Company Codeine Narcotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 175. Lannett Company Codeine Narcotic Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Lannett Company Recent Developments
Table 177. Laboratoire Riva Company Information
Table 178. Laboratoire Riva Description and Major Businesses
Table 179. Laboratoire Riva Codeine Narcotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 180. Laboratoire Riva Codeine Narcotic Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Laboratoire Riva Recent Developments
Table 182. Key Raw Materials Lists
Table 183. Raw Materials Key Suppliers Lists
Table 184. Codeine Narcotic Distributors List
Table 185. Codeine Narcotic Customers List
Table 186. Codeine Narcotic Market Trends
Table 187. Codeine Narcotic Market Drivers
Table 188. Codeine Narcotic Market Challenges
Table 189. Codeine Narcotic Market Restraints
Table 190. Research Programs/Design for This Report
Table 191. Key Data Information from Secondary Sources
Table 192. Key Data Information from Primary Sources
List of Figures
Figure 1. Codeine Narcotic Product Picture
Figure 2. Global Codeine Narcotic Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Codeine Narcotic Market Share by Type in 2022 & 2029
Figure 4. Single-ingredient Codeine Product Picture
Figure 5. Multi-ingredient Medications Product Picture
Figure 6. Global Codeine Narcotic Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Codeine Narcotic Market Share by Application in 2022 & 2029
Figure 8. Narcotic Analgesic
Figure 9. Antitussive
Figure 10. Others
Figure 11. Codeine Narcotic Report Years Considered
Figure 12. Global Codeine Narcotic Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Codeine Narcotic Revenue 2018-2029 (US$ Million)
Figure 14. Global Codeine Narcotic Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Codeine Narcotic Revenue Market Share by Region (2018-2029)
Figure 16. Global Codeine Narcotic Sales 2018-2029 ((K Units)
Figure 17. Global Codeine Narcotic Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Codeine Narcotic Sales YoY (2018-2029) & (K Units)
Figure 19. US & Canada Codeine Narcotic Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Codeine Narcotic Sales YoY (2018-2029) & (K Units)
Figure 21. Europe Codeine Narcotic Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Codeine Narcotic Sales YoY (2018-2029) & (K Units)
Figure 23. China Codeine Narcotic Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Codeine Narcotic Sales YoY (2018-2029) & (K Units)
Figure 25. Asia (excluding China) Codeine Narcotic Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Codeine Narcotic Sales YoY (2018-2029) & (K Units)
Figure 27. Middle East, Africa and Latin America Codeine Narcotic Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Codeine Narcotic Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Codeine Narcotic in the World: Market Share by Codeine Narcotic Revenue in 2022
Figure 30. Global Codeine Narcotic Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Codeine Narcotic Sales Market Share by Type (2018-2029)
Figure 32. Global Codeine Narcotic Revenue Market Share by Type (2018-2029)
Figure 33. Global Codeine Narcotic Sales Market Share by Application (2018-2029)
Figure 34. Global Codeine Narcotic Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Codeine Narcotic Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Codeine Narcotic Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Codeine Narcotic Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Codeine Narcotic Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Codeine Narcotic Revenue Share by Country (2018-2029)
Figure 40. US & Canada Codeine Narcotic Sales Share by Country (2018-2029)
Figure 41. U.S. Codeine Narcotic Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Codeine Narcotic Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Codeine Narcotic Sales Market Share by Type (2018-2029)
Figure 44. Europe Codeine Narcotic Revenue Market Share by Type (2018-2029)
Figure 45. Europe Codeine Narcotic Sales Market Share by Application (2018-2029)
Figure 46. Europe Codeine Narcotic Revenue Market Share by Application (2018-2029)
Figure 47. Europe Codeine Narcotic Revenue Share by Country (2018-2029)
Figure 48. Europe Codeine Narcotic Sales Share by Country (2018-2029)
Figure 49. Germany Codeine Narcotic Revenue (2018-2029) & (US$ Million)
Figure 50. France Codeine Narcotic Revenue (2018-2029) & (US$ Million)
Figure 51. U.K. Codeine Narcotic Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Codeine Narcotic Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Codeine Narcotic Revenue (2018-2029) & (US$ Million)
Figure 54. China Codeine Narcotic Sales Market Share by Type (2018-2029)
Figure 55. China Codeine Narcotic Revenue Market Share by Type (2018-2029)
Figure 56. China Codeine Narcotic Sales Market Share by Application (2018-2029)
Figure 57. China Codeine Narcotic Revenue Market Share by Application (2018-2029)
Figure 58. Asia Codeine Narcotic Sales Market Share by Type (2018-2029)
Figure 59. Asia Codeine Narcotic Revenue Market Share by Type (2018-2029)
Figure 60. Asia Codeine Narcotic Sales Market Share by Application (2018-2029)
Figure 61. Asia Codeine Narcotic Revenue Market Share by Application (2018-2029)
Figure 62. Asia Codeine Narcotic Revenue Share by Region (2018-2029)
Figure 63. Asia Codeine Narcotic Sales Share by Region (2018-2029)
Figure 64. Japan Codeine Narcotic Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Codeine Narcotic Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Codeine Narcotic Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Codeine Narcotic Revenue (2018-2029) & (US$ Million)
Figure 68. India Codeine Narcotic Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Codeine Narcotic Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Codeine Narcotic Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Codeine Narcotic Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Codeine Narcotic Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Codeine Narcotic Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America Codeine Narcotic Sales Share by Country (2018-2029)
Figure 75. Brazil Codeine Narcotic Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico Codeine Narcotic Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey Codeine Narcotic Revenue (2018-2029) & (US$ Million)
Figure 78. Israel Codeine Narcotic Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries Codeine Narcotic Revenue (2018-2029) & (US$ Million)
Figure 80. Codeine Narcotic Value Chain
Figure 81. Codeine Narcotic Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed